Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 2:05 AM
Ignite Modification Date: 2025-12-26 @ 12:30 AM
NCT ID: NCT01435460
Description: None
Frequency Threshold: 5
Time Frame: 15 days
Study: NCT01435460
Study Brief: Alrex® Versus Patanol in the Treatment of Seasonal Allergic Conjunctivitis(SAC)
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Patanol Ophthalmic solution containing olopatadine, 0.1% None None 0 149 0 149 View
Alrex Ophthalmic formulation containing the active ingredient loteprednol etabonate, 0.2% None None 1 151 0 151 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Deviated Septum SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA (11.0) View
Other Events(If Any):